The National Cancer Institute (NCI) has awarded a $249,814 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania, for the US Pediatric Proton and Photon Therapy Cohort study. This retrospective cohort study aims to compare the risks and benefits of proton therapy versus photon therapy for pediatric cancer patients. The contractor will retrieve de-identified clinical and treatment data from existing medical records to evaluate second cancer risks and other adverse effects between the two radiation therapy modalities. This contract has no set-aside designation. The study will build upon the foundation of the existing US Pediatric Proton Consortium Registry, which has enrolled over 3,000 pediatric proton therapy patients across 20 US centers since 2012. The goal is to quantify long-term health outcomes and risks for children undergoing these radiation therapies for cancer treatment.
Generated 6/12/24, 10:18 AM